Nasdaq · Healthcare
National Vision Holdings, Inc. (EYE)
As-reported financials and recent SEC filings for National Vision Holdings, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.99B
Net income
$29.6M
Net margin
1.5%
Diluted EPS
$0.37
ROE
3.4%
P/E (TTM)
33.1×
Market cap
$1.51B
Debt / equity
0.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.99B | $1.82B | $1.76B | $1.64B | $2.08B |
| Gross profit | — | — | — | — | — |
| Operating income | $58.8M | $-10.4M | $24.5M | $52.8M | $174.9M |
| Net income | $29.6M | $-28.5M | $-65.9M | $42.1M | $128.2M |
| Diluted EPS | $0.37 | $-0.36 | $-0.84 | $0.52 | $1.43 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →8-K2026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →Go deeper on EYE
Search National Vision Holdings, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.